PRIYA BHOGAITA: Open Payments
NPI 1598389397 · PARKLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 24 payments from 13 companies in 2025. Trend: 2023 $87 · 2024 $821 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $132 |
| United Therapeutics Corporation | 2 | $64 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| Pulmonx Corporation | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| ANI Pharmaceuticals, Inc. | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $34 |
| Grifols USA, LLC | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $31 |
Products named: FASENRA, Tyvaso, CHARTIS CATHETER, GLASSIA, TRELEGY ELLIPTA, JASCAYD, PURIFIED CORTROPHIN GEL, OPSUMIT.
Industry payments across FL — which companies pay providers there.
